These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 7076737)
41. Effect of a dopaminergic agonist, piribedil (Trivastal 50 mg LP), on visual and spatial integration in elderly subjects. Corbe C; Arnaud F; Brault Y; Janiak-Bolzinger C J Neurol; 1992; 239 Suppl 1():S22-7. PubMed ID: 1634908 [TBL] [Abstract][Full Text] [Related]
42. C-Alkylpiperazines structurally related to piribedil. XI. Sanna P; Loriga M; Cignarella G; Ferni G Farmaco Sci; 1985 Jul; 40(7):477-85. PubMed ID: 2864284 [TBL] [Abstract][Full Text] [Related]
43. Lack of effect of chronic haloperidol administration on the prolactinlowering actions of peribedil. Ravitz AJ; Moore KE J Pharm Pharmacol; 1977 Jun; 29(6):384-6. PubMed ID: 18585 [No Abstract] [Full Text] [Related]
44. Letter: Effects of low doses of a dopamine-receptor stimulator in mania. Post RM; Gerner RH; Carman JS; Bunney WE Lancet; 1976 Jan; 1(7952):203-4. PubMed ID: 54723 [No Abstract] [Full Text] [Related]
45. Clinical value of a dopaminergic agonist administration in migraine patients. Geraud G; Guell A; Courtade M; Dupui P; Bes A Headache; 1983 Jul; 23(4):191-2. PubMed ID: 6885411 [No Abstract] [Full Text] [Related]
46. Does the piribedil test permit predicting the efficacy of domperidone, a dopaminergic antagonist, in the treatment of migraine? Montastruc JL; David J; Rascol A Headache; 1985 Sep; 25(6):332-3. PubMed ID: 4055368 [No Abstract] [Full Text] [Related]
47. [The piribedil test in the diagnosis of migraine]. Dano P Presse Med; 1987 Apr; 16(13):634. PubMed ID: 2952980 [No Abstract] [Full Text] [Related]
49. Delusional Infestation in Parkinson's Disease Secondary to Piribedil Escalation: An Uncommon Case Report. Ahizoune A; Ait Berri M Cureus; 2024 Feb; 16(2):e53631. PubMed ID: 38449964 [TBL] [Abstract][Full Text] [Related]
50. Letter: Preliminary investigation of the metabolism of piribedil (ET 495); a new central dopaminergic agonist and potential anti-parkinson agent. Jenner P; Taylor AR; Campbell DB J Pharm Pharmacol; 1973 Sep; 25(9):749-50. PubMed ID: 4148514 [No Abstract] [Full Text] [Related]
51. Dissociation of metabolic and hemodynamic levodopa responses in the 6-hydroxydopamine rat model. Lerner RP; Bimpisidis Z; Agorastos S; Scherrer S; Dewey SL; Cenci MA; Eidelberg D Neurobiol Dis; 2016 Dec; 96():31-37. PubMed ID: 27544483 [TBL] [Abstract][Full Text] [Related]
52. Acute treatment of migraine. Breaking the paradigm of monotherapy. Krymchantowski AV BMC Neurol; 2004 Jan; 4():4. PubMed ID: 15005810 [TBL] [Abstract][Full Text] [Related]
53. Single photon emission computed tomography with 123I-IMP in three cases of the neuroleptic malignant syndrome. Nisijima K; Matoba M; Ishiguro T Neuroradiology; 1994 May; 36(4):281-4. PubMed ID: 7915023 [TBL] [Abstract][Full Text] [Related]
54. Cerebral circulatory and metabolic effects of piribedil. McCulloch J; Edvinsson L Eur J Pharmacol; 1980 Sep; 66(4):327-37. PubMed ID: 7418723 [TBL] [Abstract][Full Text] [Related]